Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2002

View Archived Issues

Malaria vaccine produced in milk of transgenic animals protective in monkeys

Mechanism of hypoglycemic effect of Acrp30 examined in mice

Airways-selective potassium channel opener in development by Novartis for asthma Rx

NVP-ABE-171: a PDE4 inhibitor with better activity than Ariflo in rodent models of lung inflammation

Vertex updates its progress and plans for 2002

INGN-201 does not integrate into the host cell genome, demonstrates activity as anticancer vaccine

INGN-251 endowed with both cell-killing and antimetastatic properties according to recent data

Encouraging phase Ia results of XTL-002 in hepatitis C

Peptor to begin phase II trial of DiaPep277 in treatment of LADA

4SC and Wilex enter research collaboration for second-generation uPA inhibitors

Disappointing results from phase III trial of SnET2 in wet AMD

Amerimmune initiates phase Ib study of Cytolin in HIV patients

Positive preliminary results from Corixa's phase III trial of RC-529 adjuvant

Pfizer discovers endothelin receptor antagonists selective for ETA subtype

Indole-based inhibitors of angiogenesis designed at Abbott

Grelan researchers identify benzothiazole COX-2 inhibitors useful for inflammation

Selective alpha1A-adrenoceptor antagonists claimed for therapy of BPH

New compounds from Lilly useful for treatment of conditions associated with glutamate hypofunction

Pharmacia presents protein kinase inhibitors and their potential uses in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...